8-K
filed April 5, 2022, 7:59 PM ET
ticker NIKA
CIK 0001145604
leadership
confidence high
sentiment neutral
materiality 0.75
Centennial Growth Equities changes control; Savov buys 87% stake, becomes CEO
NIKA PHARMACEUTICALS, INC
- Dimitar Slavchev Savov purchased 11,489,000 shares (87%) from Phil E. Ray and other shareholders, triggering change of control on April 1, 2022.
- Phil E. Ray resigned as Director, President, and CEO; A. Terry Ray resigned as Director and Secretary; both effective March 31, 2022, with no disagreements.
- Savov and Clifford Redekop appointed Directors March 31; Savov named President, CEO, CFO; Redekop named Secretary effective April 1, 2022.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dimitar Slavchev Savov was appointed as President, Chief Executive Officer, Chief Financial Officer at NIKA PHARMACEUTICALS, INC.
- Action
- appointed
- Role
- President, Chief Executive Officer, Chief Financial Officer
Exact text from the filing
On April 1, 2022, the board of directors accepted the resignations of Mr. Phil E. Ray and Mrs. A. Terry Ray and appointed Dimitar Slavchev Savov to serve as President, CEO, CFO and Clifford Redekop to serve as Secretary of the Corporation.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dimitar Slavchev Savov was appointed as Director at NIKA PHARMACEUTICALS, INC.
- Action
- appointed
- Role
- Director
Exact text from the filing
Effective as of March 31, 2022, the board of directors appointed Dimitar Slavchev Savov, and Clifford Redekop to serve as the Registrant’s Directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Clifford Redekop was appointed as Director at NIKA PHARMACEUTICALS, INC.
- Action
- appointed
- Role
- Director
Exact text from the filing
Effective as of March 31, 2022, the board of directors appointed Dimitar Slavchev Savov, and Clifford Redekop to serve as the Registrant’s Directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Clifford Redekop was appointed as Secretary at NIKA PHARMACEUTICALS, INC.
- Action
- appointed
- Role
- Secretary
Exact text from the filing
On April 1, 2022, the board of directors accepted the resignations of Mr. Phil E. Ray and Mrs. A. Terry Ray and appointed Dimitar Slavchev Savov to serve as President, CEO, CFO and Clifford Redekop to serve as Secretary of the Corporation.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Phil E. Ray resigned as Director, President and Chief Executive Officer at NIKA PHARMACEUTICALS, INC.
- Action
- resigned
- Role
- Director, President and Chief Executive Officer
Exact text from the filing
On March 31, 2022, Mr. Phil E. Ray resigned his position as a Director, President and Chief Executive Officer of Centennial Growth Equities, Inc. (the “Registrant ”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
A. Terry Ray resigned as Director and Secretary at NIKA PHARMACEUTICALS, INC.
- Action
- resigned
- Role
- Director and Secretary
Exact text from the filing
On March 31, 2022, Mrs. A. Terry. Ray resigned his position as a Director and Secretary of Centennial Growth Equities, Inc. (the “Registrant”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.